576 results on '"Demirkaya, Erkan"'
Search Results
2. Time for a new approach to drug development for rare systemic autoinflammatory diseases
3. Pharmacokinetics of Baricitinib in Cerebrospinal Fluid and Plasma in a Patient with SPENCD
4. Fievre et polyserite causees par la fievre mediterraneenne familiale chez une jeune femme
5. A young woman with fever and polyserositis caused by familial Mediterranean fever
6. Rare Monogenic Causes of Periodic Fevers
7. Relationship of Fatigue, Pain Interference, and Physical Disability in Children Newly Diagnosed With Juvenile Idiopathic Arthritis
8. A case report of a severe neonatal systemic vasculitis on the first day of life
9. An Overview of Conventional and Recent Treatment Options for Behcet’s Disease
10. Familial Autoinflammatory Syndrome, Behcet-Like (AISBL)
11. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry
12. Deficiency of Interleukin 1 Receptor Antagonist (DIRA)
13. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
14. Nanoparticles and cytokine response
15. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)
16. P24-038-23 The Role and Importance of Three Basic Mechanisms in Being Healthier: Inflammation, Oxidative Stress and Endothelial Dysfunction
17. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
18. Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis
19. The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases: A Quasi-Experimental Study
20. Rare Monogenic Causes of Periodic Fevers
21. How to define disease severity accurately in patients with familial Mediterranean fever
22. Evaluation of the Current Disease Scoring Systems in Familial Mediterranean Fever
23. The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
24. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
25. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease
26. The performance of classification criteria for juvenile spondyloarthropathies
27. Red Cell Distribution Width Is Independently Related to Endothelial Dysfunction in Patients With Chronic Kidney Disease
28. Assessment of autonomic functions in children with familial Mediterranean fever by using heart rate variability measurements
29. An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA)
30. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review
31. Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review
32. Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases
33. Mycoplasma pneumoniae Infections and Primary Immune Deficiencies
34. Developing guidelines for ultrarare rheumatic disorders: a bumpy ride
35. Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
36. Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
37. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
38. Brief Report: Deficiency of Complement 1r Subcomponent in Early‐Onset Systemic Lupus Erythematosus: The Role of Disease‐Modifying Alleles in a Monogenic Disease
39. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases: Cryopyrin‐Associated Periodic Syndromes, Tumour Necrosis Factor Receptor‐Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin‐1 Receptor Antagonist
40. Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
41. Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene
42. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE / PRAAS , SAVI , and AGS
43. The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
44. The relation between delivery type and cord blood levels of chitotriosidase and Troponin T
45. Paediatric Behçet’s Disease: A Comprehensive Review with an Emphasis on Monogenic Mimics
46. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
47. Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
48. Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease
49. A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis
50. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.